![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Selux Phenotyping System Cleared for Antibiotic Susceptibility Testing
Selux Phenotyping System Cleared for Antibiotic Susceptibility Testing
The FDA has granted 510(k) clearance to Selux Diagnostics for its next-generation phenotyping (NGP) system, a rapid antibiotic susceptibility testing platform for gram-positive bacteria.
The NGP system has the potential to decrease overreliance on broad-spectrum antibiotics since results provide specific susceptibility, enabling clinicians to prescribe a targeted antibiotic for gram-positive bacteria such as Staphylococcus aureus.
The FDA is currently reviewing the company’s NGP system for assessing the antibiotic susceptibility of gram-negative bacteria.
Upcoming Events
-
21Oct